embecta to Participate in Upcoming Investor Conferences in May
Embecta Corp. (Nasdaq: EMBC) has announced its participation in two significant investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Embecta Corp. (Nasdaq: EMBC) has announced its participation in two significant investor conferences. The 2022 RBC Capital Markets Global Healthcare Conference will feature a fireside chat on May 18 at 9:30 a.m. ET at the Intercontinental NY Barclay Hotel. Furthermore, the Piper Sandler Ophthalmology and Diabetes Symposium will include a virtual fireside chat on May 25 at 12:00 p.m. ET. Both presentations will be available for replay on the company’s investor relations website.
With nearly 100 years of experience in diabetes care, Embecta aims to empower diabetes patients worldwide.
Details
News Market Reaction – EMBC
The recorded move for EMBC in the trading session of this news was -1.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences:
The 2022 RBC Capital Markets Global Healthcare Conference at the Intercontinental NY Barclay Hotel in New York, NY.
- Management will participate in a fireside chat on Wednesday, May 18 at 9:30 a.m. Eastern Time.
The Piper Sandler Ophthalmology and Diabetes Symposium.
- Management will participate in a virtual fireside chat on Wednesday, May 25 at 12:00 p.m. Eastern Time.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at https://investors.embecta.com/. The webcasts will be available for replay following the conference.
About embecta
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.
CONTACTS
Investors:
Contact IR
Media:
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Christian.Glazar@embecta.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.